Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Celcuity stock | $10.6

Own Celcuity stock in just a few minutes.

Fact checked

Celcuity Inc is a diagnostics & research business based in the US. Celcuity shares (CELC) are listed on the NASDAQ and all prices are listed in US Dollars. Celcuity employs 27 staff and has a market cap (total outstanding shares value) of USD$106.9 million.

How to buy shares in Celcuity

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Celcuity. Find the stock by name or ticker symbol: CELC. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Celcuity reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$10.6, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Celcuity, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Celcuity. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Celcuity share price

Use our graph to track the performance of CELC stocks over time.

Celcuity shares at a glance

Information last updated 2020-12-26.
Latest market closeUSD$10.6
52-week rangeUSD$4.03 - USD$12.7
50-day moving average USD$9.6089
200-day moving average USD$6.8756
Wall St. target priceUSD$16.5
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.714

Buy Celcuity shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Forex
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Public
$0
Stocks, ETFs
N/A
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Celcuity stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Celcuity price performance over time

Historical closes compared with the close of $10.6 from 2020-12-18

1 week (2021-01-15) -15.87%
1 month (2020-12-23) 9.17%
3 months (2020-10-22) 99.25%
6 months (2020-07-22) 87.61%
1 year (2020-01-22) -1.94%
2 years (2019-01-22) -55.33%
3 years (2018-01-22) 19.47
5 years (2016-01-19) N/A

Celcuity financials

Gross profit TTM USD$0
Return on assets TTM -30.36%
Return on equity TTM -50.66%
Profit margin 0%
Book value $1.338
Market capitalisation USD$106.9 million

TTM: trailing 12 months

Shorting Celcuity shares

There are currently 23,221 Celcuity shares held short by investors – that's known as Celcuity's "short interest". This figure is 15.6% down from 27,498 last month.

There are a few different ways that this level of interest in shorting Celcuity shares can be evaluated.

Celcuity's "short interest ratio" (SIR)

Celcuity's "short interest ratio" (SIR) is the quantity of Celcuity shares currently shorted divided by the average quantity of Celcuity shares traded daily (recently around 8795.8333333333). Celcuity's SIR currently stands at 2.64. In other words for every 100,000 Celcuity shares traded daily on the market, roughly 2640 shares are currently held short.

However Celcuity's short interest can also be evaluated against the total number of Celcuity shares, or, against the total number of tradable Celcuity shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Celcuity's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Celcuity shares in existence, roughly 0 shares are currently held short) or 0.0039% of the tradable shares (for every 100,000 tradable Celcuity shares, roughly 4 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Celcuity.

Find out more about how you can short Celcuity stock.

Celcuity share dividends

We're not expecting Celcuity to pay a dividend over the next 12 months.

Celcuity share price volatility

Over the last 12 months, Celcuity's shares have ranged in value from as little as $4.03 up to $12.7. A popular way to gauge a stock's volatility is its "beta".

CELC.US volatility(beta: 1.38)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Celcuity's is 1.3796. This would suggest that Celcuity's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Celcuity overview

Celcuity Inc., a clinical stage biotechnology company, discovers cancer sub-types and therapeutic options for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. It develops CELsignia HSF test to diagnose two new sub-types of HER2-negative breast cancer. The company is also developing CELsignia MP test to diagnose 11 cancer sub-types in breast, lung, colon, ovarian, kidney, and bladder cancers. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site